Skip to main content
SpringerLink
Log in

Catecholamines: Role in Health and Disease

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The naturally occurring catecholamines, noradrenaline, adrenaline and dopamine, have been found in a wide range of animal and vegetable tissues, but are particularly associated with nervous tissue in animals. Of the many processes affecting the response to stimulation of catecholamine containing nerves, the synthesis of catecholamines, particularly the first enzymatic stage involving tyrosine hydroxylase, and the re-uptake process, whereby the nerve recovers much of the released catecholamine, appear to be the most significant. In peripheral tissues noradrenaline appears to be involved predominantly in the sympathetic control of blood pressure and flow while adrenaline is more important to metabolic processes especially fat and glucose turnover. Both may be released in increased amounts by various stimuli that cause stress or arousal in the body. Dopamine has not yet been shown to have any significant physiological function in peripheral tissues.

In the central nervous system, noradrenaline and dopamine are the two main catecholamines. The working of the brain is complex and involves balanced interactions between a variety of neurotransmitters, known or as yet unrecognised. However, noradrenaline appears to play a role in the central control of blood pressure, and in determining mood and activity probably by affecting the emotional drives. Dopamine is certainly important in the control of motor pathways, as shown by the dopamine deficiency syndrome in Parkinson’s disease, and is possibly of significance in the abnormal behaviour of psychotics. The role of the small concentration of adrenaline in the brain has yet to be fully established.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Antelman, S.M. and Caggiula, A.R.: Norepinephrine-dopamine interactions and behaviour. Science (NY) 195: 646–653 (1977).

    CAS  Google Scholar 

  • Axelrod, J.: Catecholamines and hypertension. Clinical Science and Molecular Medicine 51(Suppl. 3): 415s–421s (1976).

    CAS  Google Scholar 

  • Baez, L.A.: Effects of drugs on arousal and consummately behaviour; in Glick and Goldfarb (Eds) Behavioural Pharmacology pp.140–175 (Mosby, St Louis, 1976).

    Google Scholar 

  • Baldessarini, R.J.: The basis for amine hypotheses in affective disorders. Archives of General Psychiatry 32: 1087–1093 (1975).

    PubMed  CAS  Google Scholar 

  • Barrett, A.M. and Einstein, R.: Catecholamines and the cardiovascular system; in Oliver (Ed) Modern Trends in Cardiology — 3, pp.44–66 (Butterworths, London 1975).

    Google Scholar 

  • Benson, M.K.: Bronchial hyperactivity. British Journal of Diseases of the Chest 69: 227–239 (1975).

    PubMed  CAS  Google Scholar 

  • Bernheimer, H.; Birkmayer, W.; Hornykiewicz, O.; Jellinger, K. and Seitclberger, F.: Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. Journal of the Neurological Sciences 20: 415–455 (1973).

    PubMed  CAS  Google Scholar 

  • Berthelsen, S. and Pettinger, W.A.: A functional basis for the classification of α-adrenergic receptors. Life Sciences 21: 595–606 (1977).

    PubMed  CAS  Google Scholar 

  • Bird, E.D.; Barnes, J.; Iversen, L.L.; Spokes, E.G.; Mackay, A.V.P. and Shepherd, M.: Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses. Lancet 2: 1157–1159 (1977).

    PubMed  CAS  Google Scholar 

  • Bloom, F.E.: Electron microscopy of catecholamine-containing structures. Handbook of Experimental Pharmacology 33: 46–78 (Springer-Verlag, Berlin 1972).

    CAS  Google Scholar 

  • Breese, G.R.; Smith, R.D. and Cooper, B.R.: Effects of various 6-hydroxydopamine treatments during development on growth and ingestive behaviour. Pharmacology, Biochemistry and Behaviour 3: 1097–1106 (1975).

    CAS  Google Scholar 

  • Brittain, R.T.; Dean, C.M. and Jack, D.: Sympathomimetic bronchodilator drugs. Pharmacology and Therapeutics 2: 423–462 (1976).

    CAS  Google Scholar 

  • Brogden, R.N.; Speight, T.M. and Avery, G.S.: Levodopa: A review of its pharmacological properties and therapeutic uses with particular reference to Parkinsonism. Drugs 2: 262–400 (1971).

    PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Mianserin: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 16: 273–301 (1978).

    PubMed  CAS  Google Scholar 

  • Brownstein, M.J.; Mroz, E.A.; Tappaz, M.L. and Leeman, S.L.: On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra. Brain Research 135: 315–323 (1977).

    PubMed  CAS  Google Scholar 

  • Calaresu, F.R.; Faiers, A.A. and Mogenson, G.J.: Central neural regulation of heart and blood vessels in mammals. Progress in Neurobiology 5: 1–35 (1975).

    PubMed  CAS  Google Scholar 

  • Callingham, B.A.: Catecholamines in blood. Handbook of Physiology, Section 7 Endocrinology, VI: 427–445 (American Physiological Society, Washington D.C. 1975).

    Google Scholar 

  • Callingham, B.A. and Barrand, M.A.: Catecholamines in blood. Journal of Pharmacy and Pharmacology 28: 356–360 (1976).

    PubMed  CAS  Google Scholar 

  • Calne, D.; Barbeau, A. and Chase, T.N.: Dopaminergic mechanisms. Advances in Neurology 9: 1–418 (1975).

    Google Scholar 

  • Cannon, W.B. and de la Paz, D.: Emotional stimulation of adrenal secretion. American Journal of Physiology 28: 64–70 (1911).

    CAS  Google Scholar 

  • Celander, O.: The range of control exercised by the sympathicoadrenal system. Acta Physiologica Scandinavica 32(Suppl. 116): (1954).

    Google Scholar 

  • Chalmers, J.P.: Brain amines and models of experimental hypertension. Circulation Research 36: 469–480 (1975).

    PubMed  CAS  Google Scholar 

  • Christensen, N.J.; Mathias, C.J. and Frankel, H.L.: Plasma and urinary dopamine: studies during fasting and exercise in tetroplegic man. European Journal of Clinical Investigation 6: 403–409 (1976).

    PubMed  CAS  Google Scholar 

  • Clavier, R.M. and Fibiger, H.C.: On the role of ascending catecholaminergic projections in intracranial self-stimulation of the substantia nigra. Brain Research 131: 271–286 (1977).

    PubMed  CAS  Google Scholar 

  • Cox, B. and Lomax, P.: Pharmacologic control of temperature regulation. Annual Review of Pharmacology and Toxicology 17: 341–353 (1977).

    PubMed  CAS  Google Scholar 

  • Crout, J.R.: Phaeochromocytoma. Pharmacological Reviews 18: 651–657 (1966).

    PubMed  CAS  Google Scholar 

  • Crow, T.J.; Owen, F.; Cross, A.J.; Lofthouse, R. and Longden, A.: Brain biochemistry in schizophrenia (letter) Lancet 1: 36–37 (1978).

    Google Scholar 

  • Daly, J.W.: The nature of receptors regulating the formation of cyclic AMP in brain tissue. Life Sciences 18: 1349–1358 (1976).

    PubMed  CAS  Google Scholar 

  • Day, M.D. and Roach, A.G.: Central adrenoceptors and the control of arterial blood pressure. Clinical and Experimental Pharmacology and Physiology 1: 347–360 (1974).

    PubMed  CAS  Google Scholar 

  • Deacon, S.P.; Karunanayake, A. and Barnett, D.: Acebutolol, atenolol and propanolol and metabolic responses to acute hypoglycaemia in diabetics. British Medical Journal 2: 1255–1257 (1977).

    PubMed  CAS  Google Scholar 

  • Descarries, L.; Watkins, K.C. and Lapierre, Y.: Noradrenergic axon terminals in the cerebral cortex of rat HI Topometric ultrastructural analysis. Brain Research 133: 197–222 (1977).

    PubMed  CAS  Google Scholar 

  • Dolphin, A.; Sawaya, M.C.B.; Jenner, P. and Marsden, C.D.: Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulation. Naunyn-Schmiedeberg’s Archives of Pharmacology 299: 167–173 (1977).

    PubMed  CAS  Google Scholar 

  • Douglas, W.W. and Poisner, A.M.: Preferential release of adrenaline from the adrenal medulla by muscarine and pilocarpine. Nature (Lond.) 208: 1102–1103 (1965).

    CAS  Google Scholar 

  • Enna, S.J.; Stern, L.Z.; Wastek, G.J. and Yamamura, H.I.: Neurobiology and pharmacology of Huntington’s disease. Life Sciences 20: 205–212 (1977).

    PubMed  CAS  Google Scholar 

  • von Euler, U.S.: Synthesis, uptake and storage of catecholamines in adrenergic nerves. The effects of drugs. Handbood of Experimental Pharmacology 33: 186–230 (Springer-Verlag, Berlin 1972).

    Google Scholar 

  • Folkow, B. and von Euler, U.S.: Selective activation of noradrenaline and adrenaline producing cells in the cat’s adrenal gland by hypothalamic stimulation. Circulation Research 2: 191–195 (1954).

    PubMed  CAS  Google Scholar 

  • Franco-Morselli, R.; Elghozi, J.L.; Joly, E.; Di Giuilio, S. and Meyer, P.: Increased plasma adrenaline concentrations in benign essential hypertension. British Medical Journal 2: 1251–1254 (1977).

    PubMed  CAS  Google Scholar 

  • Frankenhaeuser, M.: Behaviour and circulating catecholamines. Brain Research 31: 241–262 (1971).

    PubMed  CAS  Google Scholar 

  • Frankenhaeuser, M.: Experimental approaches to the study of catecholamines and emotion; in Levi (Ed) Emotions — their parameters and measurement. pp.209–234 (Raven Press, New York 1975).

    Google Scholar 

  • Furchgott, R.F.: The classification of adrenoceptors (adrenergic receptors) An evaluation from the standpoint of receptor theory. Handbook of Experimental Pharmacology 33: 283–335 (Springer-Verlag, Berlin 1972).

    CAS  Google Scholar 

  • Gejrot, T.; Fluur, F. and Levi, L.: Sympatho-adrenomedullary activity during experimentally provoked mental stress in patients with labyrinthine defects. Acta Otolaryngologica Suppl. 244: 260–267 (1967).

    Google Scholar 

  • Goldberg, L.I.: Drug Therapy. Dopamine — clinical uses of an endogenous catecholamine, New England Journal of Medicine 291: 707–710 (1974).

    CAS  Google Scholar 

  • Haeusler, G.: Cardiovascular regulation by central adrenergic mechanisms and its alteration by hypotensive drugs. Circulation Research Suppl. I to Vols. 36–37: 223–232 (1975).

    Google Scholar 

  • Hall, R.D.; Bloom, F.E. and Olds, J.: Neuronal and neurochemical substrates of reinforcement. Neurosciences Research Program Bulletin 15: 136–314 (1977).

    Google Scholar 

  • Hartmann, E.: Schizophrenia: a theory. Psychopharmacology 49: 1–15 (1976).

    PubMed  CAS  Google Scholar 

  • Helion, R.F.: Monoamines, pyrogens and cations: Their actions on central control of body temperature. Pharmacological Reviews 26: 290–321 (1974).

    Google Scholar 

  • Herberg, L.J.; Stephens, D.N. and Franklin, K.B.J.: Catecholamines and self-stimulation: evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine. Pharmacology, Biochemistry and Behaviour 4: 575–582 (1976).

    CAS  Google Scholar 

  • Himms-Hagen, J.: Sympathetic regulation of metabolism. Pharmacological Reviews 19: 367–461 (1967).

    PubMed  CAS  Google Scholar 

  • Himms-Hagen, J.: Effects of catecholamines on metabolism. Handbook of Experimental Pharmacology 33: 363–462 (Springer-Verlag, Berlin 1972).

    CAS  Google Scholar 

  • Ho, A.D.; Feurle, G.; Gless, K.H. and Brandeis, W.E.: Normotensive familial phaeochromocytoma with predominant noradrenaline secretion. British Medical Journal 1: 81–82 (1978).

    PubMed  CAS  Google Scholar 

  • Hodge, G.K. and Butcher, L.L.: Catecholamine correlates of isolation-induced aggression in mice. European Journal of Pharmacology 31: 81–93 (1975).

    PubMed  CAS  Google Scholar 

  • Hoebel, B.G.: Pharmacologic control of feeding. Annual Review of Pharmacology and Toxicology 17: 605–621 (1977).

    PubMed  CAS  Google Scholar 

  • Hoffman, I.: A comparative review of the pharmacology of nomifensine. Brit. J. Clin. Pharmacol. 4: 69S–75S (1977).

    Google Scholar 

  • Hoekfelt, T.; Fuxe, K.; Goldstein, M. and Johansson, O.: Immunohistochemical evidence for the existence of adrenaline neurons in the rat brain. Brain Research 66: 235–251 (1974).

    Google Scholar 

  • Holzbauer, M. and Sharman, D.F.: The distribution of catecholamines in vertebrates. Handbook of Experimental Pharmacology 33: 110–185 (Springer-Verlag, Berlin 1972).

    CAS  Google Scholar 

  • Hornykiewicz, O.: Dopamine in the basal ganglia. British Medical Bulletin 29: 172–178 (1973).

    PubMed  CAS  Google Scholar 

  • Hornykiewicz, O.: Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence. Annual Review of Pharmacology and Toxicology 17: 545–559 (1977).

    PubMed  CAS  Google Scholar 

  • Horowski, R. and Gräf, K.J.: Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat. Neuroendocrinology 22: 273–286 (1976).

    PubMed  CAS  Google Scholar 

  • Iversen, L.L.: The uptake and storage of noradrenaline in sympathetic nerves (Cambridge University Press, London 1967).

    Google Scholar 

  • Iversen, L.L.; Rogawski, M.A. and Miller, R.J.: Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum. Molecular Pharmacology 12: 251–262 (1976).

    PubMed  CAS  Google Scholar 

  • Jarrott, B.; Tomlinson, L. and Louis, W.J.: Catecholamine-metabolizing enzymes in human adrenal glands and phaeochromocytomas. Clinical and Experimental Pharmacology and Physiology 2: 431–432 (1975).

    Google Scholar 

  • Johnson, B.F.; Smith, I.K.; La Brooy, J. and Bye, C.: The nature of the β-adrenoreceptor controlling plasma renin activity in man. Clinical Science and Molecular Medicine 51: 113s–115s (1976).

    CAS  Google Scholar 

  • de Jong, W.; Zandberg, P.; Versteeg, D.H.G. and Palkovits, M.: Brain-stem structures and catecholamines in the control of arterial blood pressure in the rat. Clinical Science and Molecular Medicine 51: 381s–383s (1976).

    Google Scholar 

  • Jouvet, M.: The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle. Ergebnisse der Physiologie (Reviews of Physiol.) 64: 166–307 (1972).

    CAS  Google Scholar 

  • Kizer, J.S.; Palkouits, M. and Brownstein, M.J.: The projections of the A8, A9 and A10 dopaminergic cell bodies: Evidence for a nigral-hypothalamic-median eminence dopaminergic pathway. Brain Research 108: 363–370 (1976).

    PubMed  CAS  Google Scholar 

  • Kostrzewa, R.M. and Jacobowitz, D.M.: Pharmacological actions of 6-hydroxydopamine. Pharmacological Reviews 26: 199–288 (1974).

    PubMed  CAS  Google Scholar 

  • Kovacevic, R. and Radulovacki, M.: Monoamine changes in the brain of cats during slow-wake sleep. Science 193: 1025–1027 (1976).

    PubMed  CAS  Google Scholar 

  • Kruk, Z.L. and Zarrindast, M.R.: Mazindol anorexia is mediated by activation of dopaminergic mechanisms. British Journal of Pharmacology 58: 367–372 (1976).

    PubMed  CAS  Google Scholar 

  • Krulich, L.; Giachetti, A.; Marchlewaska-koj, A.; Hefko, E. and Jameson, H.G.: On the role of the central noradrenergic and dopaminergic systems in the regulation of T.S.H. secretion in the rat. Endocrinology 100: 496–505 (1977).

    PubMed  CAS  Google Scholar 

  • Kurien, Y.A.; Yates, P.A. and Oliver, M.F.: The role of free fatty acids in the production of ventricular arrhythmias after acute coronary artery occlusion. European Journal of Clinical Investigation 1: 225–241 (1971).

    PubMed  CAS  Google Scholar 

  • Laduron, P.; de Bie, K. and Leysen, J.: Specific effect of haloperidol on dopamine turnover in the frontal cortex. Naunyn-Schmiedeberg’s Archives of Pharmacology 296: 183–185 (1977).

    PubMed  CAS  Google Scholar 

  • Langer, S.Z.: Presynaptic receptors and their role in the regulation of transmitter release. British Journal of Pharmacology 60: 481–497 (1977).

    PubMed  CAS  Google Scholar 

  • Laverty, R.: On the roles of dopamine and noradrenaline in animal behaviour. Progress in Neurobiology 3: 33–70 (1975).

    PubMed  CAS  Google Scholar 

  • Levi, L.: Stress and distress in response to psychosocial stimuli. Acta Medica Scandinavica (Suppl. 528) (1972).

    Google Scholar 

  • Levi, L.: Emotions — their Parameters and Measurement (Raven Press, New York 1975).

    Google Scholar 

  • Lewis, G.P.: Physiological mechanisms controlling secretary activity of adrenal medulla. Handbook of Physiology — Endocrinology VI, pp.309–319 (American Physiological Society, Washington D.C. 1975).

    Google Scholar 

  • Lidberg, L.; Levander, S.E.; Schalling, D. and Lidberg, Y.: Excretion of adrenaline and noradrenaline as related to real life stress and psychopathy. Reports from the Laboratory for Clinical Stress Research 50: 1–15 (1976).

    Google Scholar 

  • Liebowitz, S.F.: Amphetamine — possible site and mode of action for producing anorexia in the rat Brain Research 84: 160–167 (1975).

    Google Scholar 

  • Lindvall, O. and Björklund, A.: The organization of the ascending catecholamine neuron systems in the rat brain. Acta Physiologica Scandinavica Suppl. 412: (1974).

  • Lindvall, O.; Björklund, A.; Moore, R.Y. and Stenevi, U.: Mesencephalic dopamine neurons projecting to neocortex. Brain Research 81: 325–331 (1974).

    PubMed  CAS  Google Scholar 

  • van Loon, G.: Brain catecholamines and ACTH secretion; in Ganong and Martini (Eds) Frontiers in Neuroendocrinology, 1973, pp.209–247 (Oxford University Press, Oxford 1973).

    Google Scholar 

  • Louis, W.J.; Jarrott, B. and Doyle, A.E.: The role of noradrenaline and other transmitter hormones in the pathogenesis of hypertension. Clinical Science and Molecular Medicine 51(Suppl. 3): 427s–430s (1976).

    CAS  Google Scholar 

  • Maas, J.W.: Catecholamines and depression: a further specification of the catecholamine hypothesis of the affective disorders; in Friedhoff (Ed) Catecholamines and Behaviour — 2 Neuropsychopharmacology, pp.119–133 (Plenum Press, New York 1975).

    Google Scholar 

  • Manger, W.M.; Fröhlich, E.D.; Gifford, R.W. and Dunstan, H.P.: Norepinephrine infusion in normal subjects and patients with essential or renal hypertension: effect on blood pressure, heart rate and plasma catecholamine concentrations. Journal of Clinical Pharmacology 16: 129–141 (1976).

    PubMed  CAS  Google Scholar 

  • Martin, J.B.: Neural regulation of growth hormone secretion. New England Journal of Medicine 288: 1384–1393 (1973).

    PubMed  CAS  Google Scholar 

  • Martinovic, J.V. and McCann, S.M.: Effect of lesions in the ventral noradrenergic tract produced by microinjection of 6-hydroxydopamine on gonadotropin release in the rat. Endocrinology 100: 1206–1213 (1977).

    PubMed  CAS  Google Scholar 

  • Mason, J.W.: A review of psychoendocrine research on the sympathetic-adrenal medullary system. Psychosomatic Medicine 30: 631–653 (1968).

    PubMed  Google Scholar 

  • Mason, S.T. and Iversen, S.D.: An investigation of the role of cortical and cerebellar noradrenaline in associative motor learning in the rat. Brain Research 134: 513–527 (1977).

    PubMed  CAS  Google Scholar 

  • Mathias, C.J.; Christensen, N.J.; Corbett, J.L.; Frankel, H.L. and Spalding, J.M.K.: Plasma catecholamines during paroxysmal neurogenic hypertension in quadraplegic man. Circulation Research 39: 204–208 (1976).

    PubMed  CAS  Google Scholar 

  • Moskowitz, M.A. and Wurtman, R.J.: Catecholamines and neurologic diseases. New England Journal of Medicine 293: 332–338 (1975).

    PubMed  CAS  Google Scholar 

  • Munro, A.F. and Robinson, R. The catecholamine content of the peripheral plasma in human subjects with complete transverse lesions of the spinal cord. Journal of Physiology 154: 244–253 (1960).

    PubMed  CAS  Google Scholar 

  • Nelson, P.G.: Effect of heparin on serum free-fatty-acids, plasma catecholamines, and the incidence of arrhythmias following acute myocardial infarction. British Medical Journal 3: 735–737 (1970).

    PubMed  CAS  Google Scholar 

  • Nestel, P.J.: Blood pressure and catecholamine excretion after mental stress in labile hypertension. Lancet 1: 692–694 (1969).

    PubMed  CAS  Google Scholar 

  • Olds, J.: Brain stimulation and the motivation of behaviour. Progress in Brain Research 45: 401–426 (1976).

    PubMed  CAS  Google Scholar 

  • Peterson, D.W. and Laverty, R.: Operant behavioural and neurochemical effects after neonatal 6-hydroxydopamine treatment. Psychopharmacology 50: 55–60 (1976).

    PubMed  CAS  Google Scholar 

  • Pinder, R.M.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Viloxazine: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 13: 401–421 (1977).

    PubMed  CAS  Google Scholar 

  • Poirier, L.; Filion, M.; Langelier, P. and Larochelle, L.: Brain nervous mechanisms involved in the so-called extra pyramidal motor and psychomotor disturbances. Progress in Neurobiology 5: 197–244 (1975).

    Google Scholar 

  • Pradhan, S.N.: Aggression and central neurotransmitters. International Review of Neurobiology 18: 213–262 (1975).

    PubMed  CAS  Google Scholar 

  • Randrup, A.; Munkvad, I.; Fog, R. and Ayhan, I.H.: Catecholamines in activation, stereotypy and level of mood; in Friedhoff (Ed) Catecholamines and behaviour — I Basic Neurobiology, pp.89–107 (Plenum Press, New York 1975).

    Google Scholar 

  • Ranje, C. and Ungerstedt, U.: Lack of acquisition in dopamine denervated animals tested in an underwater Y-maze. Brain Research 134: 95–111 (1977).

    PubMed  CAS  Google Scholar 

  • Reid, J.L. and Dollery, C.T.: Central and peripheral catecholamine mechanisms in circulatory control. Cardiology 61(Suppl. 1): 113–124 (1976).

    PubMed  Google Scholar 

  • Rolls, E.T.: The neural basis of brain-stimulation reward. Progress in Neurobiology 3: 71–160 (1975).

    Google Scholar 

  • Ross, C.A.; Trulson, M.E. and Jacobs, B.L.: Depletion of brain serotonin following intraventricular 5,7-dihydroxytryptamine fails to disrupt sleep in rat. Brain Research 114: 517–523 (1976).

    PubMed  CAS  Google Scholar 

  • Schildkraut, J.J.: Neuropharmacology of the affective disorders. Annual Review of Pharmacology 13: 427–454 (1973).

    PubMed  CAS  Google Scholar 

  • Scriabine, A., Clineschmidt, B.V. and Sweet, C.S.: Central noradrenergic control of blood pressure. Annual Review of Pharmacology and Toxicology 16: 113–123 (1976).

    PubMed  CAS  Google Scholar 

  • Seeman, P.: Anti-schizophrenic drugs — membrane receptor sites of action. Biochemical Pharmacology 26: 1741–1748 (1977).

    PubMed  CAS  Google Scholar 

  • Smith, A.D. and Winkler, H.: Fundamental mechanisms in the release of catecholamines. Handbook of Experimental Pharmacology 33: 538–617 (Springer-Verlag, Berlin 1972).

    CAS  Google Scholar 

  • Snyder, S.H.: The dopamine hypothesis of schizophrenia — focus on the dopamine receptor. American Journal of Psychiatry 133: 197–202 (1976).

    PubMed  CAS  Google Scholar 

  • Stone, R.A.; Lilley, J.L. and Golden, J.: Plasma dopamine-betahydroxylase activity in phaeochromocytoma. Clinical Endocrinology 5: 181–185 (1976).

    PubMed  CAS  Google Scholar 

  • Stumpe, K.O.; Kolloch, R.; Higuchi, M.; Kruch, F. and Vetter, H.: Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Lancet 2: 211–220 (1977).

    PubMed  CAS  Google Scholar 

  • Taylor, K.M. and Laverty, R.: The interaction of chlordiazepoxide, diazepam and nitrazepam with catecholamines and histamine in regions of the rat brain; in Garattini, Mussini and Randall (Eds) The Benzodiazepines, pp.191–202 (Raven Press, New York1973).

    Google Scholar 

  • Theorell, T.; Lind, E.; Froberg, J.; Karlsson, C.G. and Levi, L.: A longitudinal study of 21 subjects with coronary heart disease: Life changes, catecholamine excretion and related biochemical reactions. Psychosomatic Medicine 34: 505–516 (1972).

    PubMed  CAS  Google Scholar 

  • Thomas, D.J.B.; Gill, B.; Brown, P. and Stubbs, W.A.: Salbutamol-induced diabetic ketoacidosis. British Medical Journal 2: 438 (1977).

    PubMed  CAS  Google Scholar 

  • Ungerstedt, U.: Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiologica Scandinavica Suppl. 367: 95–122 (1971).

    CAS  Google Scholar 

  • Versteeg, D.H.G.; Van der Gugten, J.; deJong, W. and Palkovits, M.: Regional concentrations of noradrenaline and dopamine in rat brain. Brain Research 113: 563–574 (1976).

    PubMed  CAS  Google Scholar 

  • Vogt, M.: Influence of circulating catecholamines on the central nervous system. Handbook of Physiology; Section 7: Endocrinology, Vol. 6, Adrenal Gland, pp.667–668 (1975).

    CAS  Google Scholar 

  • Westerink, B.H.C.; Lejeune, B.; Korf, J. and van Praag, H.M.: On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs. European Journal of Pharmacology 42: 179–190 (1977).

    PubMed  CAS  Google Scholar 

  • Westfall, T.C.: Local regulation of adrenergic neurotransmission. Physiological Reviews 57: 659–728 (1977).

    PubMed  CAS  Google Scholar 

  • Wiggins, J.F. and Fernstrom, J.D.: L-dopa inhibits prolactin secretion in proestrous rats. Endocrinology 101: 469–474 (1977).

    PubMed  CAS  Google Scholar 

  • Wijnen, H.J.L.; Versteeg, D.H.G.; Palkovits, M. and de Jong, W.: Increased adrenaline content of individual nuclei of the hypothalamus and the medulla oblongata of genetically hypertensive rats. Brain Research 135: 180–185 (1977).

    PubMed  CAS  Google Scholar 

  • Winkler, H. and Smith, A.D.: Phaeochromocytoma and other catecholamine-producing tumours. Handbook of Experimental Pharmacology 33: 900–933 (Springer-Verlag, Berlin 1972).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of Otago Medical School, P.O. Box 913, Dunedin, New Zealand

    R. Laverty

Authors
  1. R. Laverty
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laverty, R. Catecholamines: Role in Health and Disease. Drugs 16, 418–440 (1978). https://doi.org/10.2165/00003495-197816050-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-197816050-00003

Keywords

Search

Navigation